AbelZeta
Thu Le Trinh is a Senior Scientist at Cellular Biomedicine Group, with experience in developing novel pre-clinical processes for Tumor Infiltrating Lymphocytes to treat Non-Small Cell Lung Cancer. Prior to this role, Thu Le Trinh worked as a Scientist I at Elstar Therapeutics Inc., focusing on designing assays for T and NK-cell engagers for Peripheral T cell Lymphoma and Acute Myeloid Leukemia. Additionally, Thu Le Trinh has extensive experience in industry collaborations and clinical trial assistance, with a Ph.D. in Microbiology and Immunology from the University of Florida.
This person is not in any offices
AbelZeta
1 followers
AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies.